Glioblastoma, often referred to as GBM, is a formidable foe in the realm of cancer. Let's delve into some key questions surrounding this condition, without dwelling on grim statistics:
What is Glioblastoma? Glioblastomas are aggressive grade 4 brain tumors characterized by abnormal cells that rapidly grow and spread. They are notorious for creating new blood vessels and accumulating dead cells at their core.
Where are Glioblastomas located? Primarily found in the frontal lobe, followed by the temporal, parietal, and occipital lobes of the brain.
What are the most common symptoms of Glioblastomas? Symptoms include seizures, severe headaches, memory and language issues, personality changes, muscle weakness, fatigue, coordination problems, and sensory impairments.
What does treatment look like? Treatment typically involves a combination of surgery, radiation therapy, chemotherapy, clinical trials, Tumor Treating Fields (TTFields), and targeted therapies.
Why are Glioblastomas so hard to treat? Their rapid growth, invasive nature, and the blood-brain barrier's protective effect make complete removal challenging. Additionally, their heterogeneous nature and potential for change over time pose treatment hurdles.
What percentage of Brain Tumors are made up of Glioblastoma? Glioblastomas account for approximately 14% of all primary brain tumors, with over 12,000 new cases diagnosed annually in the United States.
Do men or women get Glioblastoma? Glioblastomas are slightly more prevalent in men than in women.
What is the age range for Glioblastoma patients? While they can occur at any age, glioblastomas are more common in older individuals, particularly those aged 65 to 74, with a median age of diagnosis at 65.
Why do people get Glioblastoma? The exact cause remains unknown, although certain genetic syndromes and exposure to ionizing radiation are associated with increased risk. Most patients, however, have no identifiable risk factors.
Is GBM treatment effective? Standard treatments have extended survival rates, with some patients living several years post-diagnosis. However, these treatments are not curative, emphasizing the need for ongoing research and innovation in treatment strategies.
Understanding these FAQs can provide insight and clarity for those affected by glioblastoma and their loved ones as they navigate this challenging journey.
Cited Research
Glioblastoma (GBM) - American Brain Tumor Association: Learn more. American Brain Tumor Association. (2023, July 11).
Weingart., J. (2023, October 30). Glioblastoma multiforme (GBM): Advancing treatment for a dangerous brain tumor. Johns Hopkins Medicine.
Comments